Pallas Health vs Maximus: clinician choice or lowest flat rate
Pallas Health vs Maximus: quick verdict
Pallas Health and Maximus both offer online, clinician-reviewed access to GLP-1 weight-loss care, but Pallas emphasizes clinician choice between brand-name pens and compounded preparations while Maximus emphasizes a low flat compounded price. Early verdict: choose Pallas when you want clinician access to brand-name or compounded options; choose Maximus when a lower flat monthly compounded rate is the priority.
Key differences at a glance: Pallas Health vs Maximus
The comparison centers on four supported differences: medication options, pricing structure and starting prices, clinician and program features, and availability or program scale. Each point below compares Pallas Health directly with Maximus using only supplied facts.
1. Medication options and branded availability
Pallas Health: clinician-personalized choice between FDA-approved brand-name GLP-1s such as Wegovy, Ozempic, Zepbound and Mounjaro, or compounded semaglutide and tirzepatide prepared in the USA when a brand medication is not the right fit. Maximus: offers compounded semaglutide only, with no branded Ozempic, Wegovy, or Zepbound published in the supplied evidence.
2. Pricing structure and starting price
Pallas Health lists compounded semaglutide starting at $139 for the first month, then $597 every 12 weeks, a $199/month average. Compounded tirzepatide starts at $179 first month, then $897 every 12 weeks, a $299/month average. Brand-name medications at Pallas are presented as cash-pay monthly prices for specific brands as published. Maximus advertises a low flat rate of $132.99/month for compounded semaglutide and frames itself as one of the lower flat rates on the list. Maximus uses a straightforward direct-pay monthly price.
3. Clinician review, program features and customer experience
Pallas: a US-licensed clinician reviews your health history and personalizes the plan; provider care, ongoing check-ins and care-team messaging are included in one all-in plan price with no membership fee. Pallas is 100% online and asynchronous in most states with a video visit required in seven states and Washington, D.C. Pallas notes refunded in full if a clinician decides treatment is not right for you, free expedited shipping and a self-serve portal plus a companion app. Maximus: prescriptions are approved by licensed doctors and filled through trusted U.S. pharmacies, with convenient telemedicine access and no in-person visits. Maximus emphasizes telemedicine convenience, licensed-doctor approvals and trusted US pharmacies but has fewer public reviews and a smaller public track record according to the supplied evidence.
4. Availability, scale and program limitations
Maximus is currently available in all 50 states except Mississippi in the supplied evidence. Pallas requires a video visit in a limited set of states (seven plus D.C.) and is asynchronous in most states (43 of 50 need no video visit). Maximus is described as a smaller, newer platform with a thinner public track record compared with larger competitors; Pallas highlights LegitScript Healthcare Merchant Certification and published clinical disclosures in the supplied facts.
| Criteria | Pallas Health | Maximus |
|---|---|---|
| Medication types | Brand-name GLP-1s or compounded semaglutide/tirzepatide | Compounded semaglutide only (per supplied evidence) |
| Starting price (compounded) | $139 first month; then $597/12 weeks ($199/mo avg) | $132.99 per month flat |
| Provider care included | Provider care, check-ins and messaging included in plan price | Prescriptions approved by licensed doctors; telemedicine access |
| Shipping and pharmacies | Free expedited shipping; compounded in the USA via licensed pharmacies | Free priority shipping; filled through trusted U.S. pharmacies |
| Regulatory note | Compounded medications are not FDA-approved | Compounded medications are not FDA-approved |
What each provider emphasizes
Pallas emphasizes clinician selection between brand-name products and compound options, an all-in plan price that includes provider care and messaging, and specific renewal cadence for compounded plans that renew every 12 weeks. Maximus emphasizes a low flat per-month compounded semaglutide price, telemedicine convenience with licensed-doctor prescriptions, and filling through trusted U.S. pharmacies.
See Maximus pricing and availability
Costs, billing and cancellation notes
Pallas is cash-pay only and does not bill insurance; its FAQ notes FSA or HSA use may require a Letter of Medical Necessity. Compounded plans at Pallas renew every 12 weeks so cancellation timing matters. Maximus is a direct-pay model and does not bill insurance; the monthly cost is what you pay according to the supplied evidence. If Maximus does not approve treatment, the supplied evidence states medication costs will be fully refunded.
Bottom line and how to choose
In a direct Pallas Health vs Maximus comparison: Pallas is better suited for patients who want a clinician to choose between brand-name pens and a per-patient compounded preparation and who value provider care and messaging included in one plan price. Maximus is better suited for patients who prioritize a lower flat monthly compounded semaglutide price and a simple telemedicine workflow filled through trusted U.S. pharmacies.
Choose Pallas Health if…
- You want access to FDA-approved brand-name GLP-1s or a clinician-personalized compounded alternative.
- You prefer an all-in plan price that includes provider care, check-ins and messaging and do not need insurance billing.
- You value a provider with published clinical disclosures and LegitScript Healthcare Merchant Certification as stated in the supplied evidence.
Choose Maximus if…
- You prioritize a lower flat monthly compounded semaglutide rate at $132.99/month as described in the supplied evidence.
- You want a simple telemedicine process with licensed-doctor prescriptions filled through trusted U.S. pharmacies and wide state availability per the supplied facts.